HB 61 Delaware House · 150th General Assembly (2019-2020)

AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO THE UNIFORM CONTROLLED SUBSTANCES ACT.

Summary
Benzodiazepine drugs that are approved for medical use in the United States are classified by the federal Drug Enforcement Agency as Schedule IV. Fourteen benzodiazepine drugs are currently listed on Schedule IV of the Uniform Controlled Substances Act, § 4720 of Title 16. Benzodiazepine drugs have a serious potential for abuse. This Act adds both additional benzodiazepine drugs by name and the category of benzodiazepine drugs to Schedule IV of the Uniform Controlled Substances Act so that all current and future benzodiazepine drugs are included on Schedule IV in Delaware, whether or not the specific drug is approved for medical use in the United States.
Bill status signed all 5 stages cleared
Introduction
Feb 2019
Committee Review
Mar 2019
House Passage
Mar 2019
Senate Passage
Apr 2019
Signed into Law
Jun 2019
Introduced Feb 28, 2019 Signed Jun 19, 2019
Floor votes · House Mar 19, 2019

How they voted

This bill passed the Senate by voice vote (no roll call recorded).
Full legislative history

Actions timeline

Total actions
7
Key actions
5
Committee
2
Jun 19, 2019
Signed into law
Signed by Governor
executive
Apr 9, 2019
Upper · Passed
Passed By Senate. Votes: 21 YES
upper
Mar 27, 2019
Upper · Passed
Reported Out of Committee (Health & Social Services) in Senate with 3 On Its Merits
upper
Mar 19, 2019
Introduced
Assigned to Health & Social Services Committee in Senate
upper
Mar 19, 2019
Lower · Passed
Passed By House. Votes: 40 YES 1 ABSENT
lower
Mar 6, 2019
Lower · Passed
Reported Out of Committee (Health & Human Development) in House with 10 On Its Merits
lower
Feb 28, 2019
Introduced
Introduced and Assigned to Health & Human Development Committee in House
lower
3 primary · 9 co-sponsors

Sponsors